This biotech firm develops therapies for rare, complement-driven diseases, with a focus on autoimmune and inflammatory conditions.

Amid these staggering projections, there are still many unknowns about neurodegenerative diseases and memory loss, but within ...

Experts working across oncology are exploring how different treatment approaches can work together to improve outcomes for ...

Dr.Thomas L. F. Montgomery Andresen joins from T-Cypher BioFollows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine releaseCommit is poised to nominate its ...

A new rehab gym for people with neurological injuries or conditions just opened in Tulsa. It offers activity-based therapy, ...

The Telangana government is exploring a pod-based transport system to improve last-mile connectivity for commuters using the ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced an oral presentation during the Late-Breaking ...

Researchers will join a new NIH-supported network working to develop novel approach methodologies that complement or replace animal testing ...

Keathley Landscaping has announced enhanced drainage system installation services designed to address water management challenges affecting residential and commercial properties throughout North Texas ...

Finance Minister Muhammad Aurangzeb on Wednesday emphasised that Pakistan must gradually move toward a “more balanced financial system”, in which capital markets would complement the banking sector in ...

Designed for fleet air defense, the F-14 was armed with a potent long-range missile and, with a powerful new radar, could engage multiple airborne targets at once. The United States Navy's F-14 Tomcat ...

Kia's Product Planning chief gave us a surprisingly direct answer about whether the 2027 Telluride will replace or complement the EV9.